Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
5.46
-0.04 (-0.73%)
At close: Feb 27, 2026, 4:00 PM EST
5.43
-0.03 (-0.55%)
After-hours: Feb 27, 2026, 7:49 PM EST
Aldeyra Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Aldeyra Therapeutics stock have an average target of 9.50, with a low estimate of 9.00 and a high estimate of 10. The average target predicts an increase of 73.99% from the current stock price of 5.46.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 10, 2025.
Analyst Ratings
The average analyst rating for Aldeyra Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +64.84% | Nov 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +83.15% | May 19, 2025 |
| BTIG | BTIG | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +64.84% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +83.15% | Apr 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +83.15% | Mar 3, 2025 |
Financial Forecast
Revenue This Year
24.74M
Revenue Next Year
33.70M
from 24.74M
Increased by 36.25%
EPS This Year
-0.29
from -0.94
EPS Next Year
-0.50
from -0.29
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 152.8M | 86.0M | ||||
| Avg | 24.7M | 33.7M | ||||
| Low | n/a | 15.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 247.7% | ||||
| Avg | - | 36.2% | ||||
| Low | - | -36.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.55 | -0.37 | ||||
| Avg | -0.29 | -0.50 | ||||
| Low | -0.69 | -0.61 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.